Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting Report

Efficacy and safety of 177Lu-PSMA radionuclide treatment in patients with diffuse bone marrow involvement: a multicenter retrospective study

Andrei Gafita, Wolfgang Fendler, Wang Hui, Shahneen Sandhu, Manuel Weber, Rouzbeh Esfandiari, Jeremie Calais, Isabel Rauscher, Hendrik Rathke, Robert Tauber, Ebrahim Desspahand, Wolfgang Weber, Ken Herrmann, Johannes Czernin, Matthias Eiber and Michael Hofman
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1284;
Andrei Gafita
1Department of Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Fendler
2Department of Nuclear Medicine University Hospital Essen Essen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wang Hui
1Department of Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shahneen Sandhu
3Department of Medical Oncology Peter MacCallum Cancer Center Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manuel Weber
2Department of Nuclear Medicine University Hospital Essen Essen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rouzbeh Esfandiari
4Excel Diagnostics and Nuclear Oncology Center Houston TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremie Calais
5Ahmanson Translational Theranostics Division UCLA Los Angeles CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabel Rauscher
1Department of Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hendrik Rathke
6Department of Nuclear Medicine University Hospital Heidelberg Heidelberg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Tauber
7Department of Urology Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ebrahim Desspahand
4Excel Diagnostics and Nuclear Oncology Center Houston TX United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Weber
1Department of Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken Herrmann
2Department of Nuclear Medicine University Hospital Essen Essen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Czernin
5Ahmanson Translational Theranostics Division UCLA Los Angeles CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthias Eiber
1Department of Nuclear Medicine Technical University Munich Munich Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Hofman
8Department of Nuclear Medicine Peter MacCalllum Cancer Institute Melbourne Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 61 no. supplement 1 1284

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2020.

Copyright & Usage 
© 2020

Author Information

  1. Andrei Gafita1,
  2. Wolfgang Fendler2,
  3. Wang Hui1,
  4. Shahneen Sandhu3,
  5. Manuel Weber2,
  6. Rouzbeh Esfandiari4,
  7. Jeremie Calais5,
  8. Isabel Rauscher1,
  9. Hendrik Rathke6,
  10. Robert Tauber7,
  11. Ebrahim Desspahand4,
  12. Wolfgang Weber1,
  13. Ken Herrmann2,
  14. Johannes Czernin5,
  15. Matthias Eiber1 and
  16. Michael Hofman8
  1. 1Department of Nuclear Medicine Technical University Munich Munich Germany
  2. 2Department of Nuclear Medicine University Hospital Essen Essen Germany
  3. 3Department of Medical Oncology Peter MacCallum Cancer Center Melbourne Australia
  4. 4Excel Diagnostics and Nuclear Oncology Center Houston TX United States
  5. 5Ahmanson Translational Theranostics Division UCLA Los Angeles CA United States
  6. 6Department of Nuclear Medicine University Hospital Heidelberg Heidelberg Germany
  7. 7Department of Urology Technical University Munich Munich Germany
  8. 8Department of Nuclear Medicine Peter MacCalllum Cancer Institute Melbourne Australia

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2020 to April 2025

AbstractFullPdf
May 20202400
Jun 20205100
Jul 20204500
Aug 20203400
Sep 20202600
Oct 20204200
Nov 20203100
Dec 20205400
Jan 20213500
Feb 20211900
Mar 20213100
Apr 20218400
May 20211900
Jun 20211800
Jul 20213000
Aug 2021700
Sep 2021500
Oct 2021500
Nov 2021900
Dec 2021800
Jan 20221000
Feb 2022700
Mar 20221500
Apr 20223800
May 20226400
Jun 2022900
Jul 2022700
Aug 2022800
Sep 20221100
Oct 20221000
Nov 2022300
Dec 2022300
Jan 2023900
Feb 2023700
Mar 20231200
Apr 2023600
May 2023700
Jun 2023400
Jul 2023700
Aug 2023700
Sep 2023800
Oct 2023600
Nov 20231000
Dec 20231100
Jan 2024500
Feb 2024600
Mar 2024600
Apr 20241200
May 2024800
Jun 20241300
Jul 2024900
Aug 2024900
Sep 20242100
Oct 2024800
Nov 2024500
Dec 2024700
Jan 20251200
Feb 2025500
Mar 20251100
Apr 2025800
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy and safety of 177Lu-PSMA radionuclide treatment in patients with diffuse bone marrow involvement: a multicenter retrospective study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Efficacy and safety of 177Lu-PSMA radionuclide treatment in patients with diffuse bone marrow involvement: a multicenter retrospective study
Andrei Gafita, Wolfgang Fendler, Wang Hui, Shahneen Sandhu, Manuel Weber, Rouzbeh Esfandiari, Jeremie Calais, Isabel Rauscher, Hendrik Rathke, Robert Tauber, Ebrahim Desspahand, Wolfgang Weber, Ken Herrmann, Johannes Czernin, Matthias Eiber, Michael Hofman
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1284;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Efficacy and safety of 177Lu-PSMA radionuclide treatment in patients with diffuse bone marrow involvement: a multicenter retrospective study
Andrei Gafita, Wolfgang Fendler, Wang Hui, Shahneen Sandhu, Manuel Weber, Rouzbeh Esfandiari, Jeremie Calais, Isabel Rauscher, Hendrik Rathke, Robert Tauber, Ebrahim Desspahand, Wolfgang Weber, Ken Herrmann, Johannes Czernin, Matthias Eiber, Michael Hofman
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1284;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Rest Dose Spillover Correction of Stress Blood Flow Measurements in Digital Rb-82 Myocardial Perfusion PET/CT Imaging
  • Radiolabeled hyaluronic acid (HA) fragments for lymphatic imaging
  • Reduction of injected activity for MBF with a CZT Cardiac SPECT Camera
Show more

GU - Radioligand Therapy (Poster Session)

  • Intermittent Lu-177-PSMA-617 therapy of metastatic castration-resistant prostate cancer in early responders
  • Clinical utility of 18F-NaF and 68Ga-PSMA PET/CT as prognostic marker in patients with metastatic prostate cancer treated with Radium-223
  • Radioligand Therapy with 177Lu-PSMA-617 in Patients with Diffuse Bone Marrow Involvement: Safety and Efficacy Results
Show more GU - Radioligand Therapy (Poster Session)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire